Literature DB >> 11502832

A prospective, randomized study of endometrial telomerase during the menstrual cycle.

C D Williams1, J F Boggess, L R LaMarque, W R Meyer, M J Murray, M A Fritz, B A Lessey.   

Abstract

The purpose of this study was to characterize telomerase activity during the menstrual cycle, focusing on the luteal phase. A total of 84 endometrial biopsy samples were obtained from 72 participants. Daily urinary LH testing (OvuQuick, Quidel) was used to establish the day of the LH rise, and participants were randomized to return during the secretory phase. Twelve women returned on the identical day during the luteal phase of a subsequent cycle to allow intercycle comparisons of telomerase activity. Telomerase activity was evaluated using a modified TRAP-eze (Intergen) detection protocol. At the time of each endometrial biopsy, serum estrogen and progesterone were measured. Proliferative phase endometrium showed high telomerase activity. At the onset of the luteal phase telomerase activity was high, but it decreased during the early luteal phase, disappeared by the midluteal phase (6 d after LH surge detected), and then rose to moderate levels in the late luteal phase beginning on luteal d 10. Serum progesterone levels were inversely related to telomerase activity. In conclusion, endometrial telomerase activity is dynamic: high during the proliferative phase but inhibited during the midsecretory phase of the menstrual cycle. The timing of expression coincides with the rise and fall of progesterone levels and the time period of maximal uterine receptivity for embryo implantation. This supports a relationship between sex steroid levels and telomerase regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502832     DOI: 10.1210/jcem.86.8.7729

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis.

Authors:  R Sato; C Maesawa; K Fujisawa; K Wada; K Oikawa; Y Takikawa; K Suzuki; H Oikawa; K Ishikawa; T Masuda
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

2.  Immortalization of epithelial progenitor cells mediated by resveratrol.

Authors:  V P Pearce; J Sherrell; Z Lou; L Kopelovich; W E Wright; J W Shay
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

3.  Differential roles of telomere attrition in type I and II endometrial carcinogenesis.

Authors:  Esra A Akbay; Cristina M Contreras; Samanthi A Perera; James P Sullivan; Russell R Broaddus; John O Schorge; Raheela Ashfaq; Hossein Saboorian; Kwok-Kin Wong; Diego H Castrillon
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

4.  The status of telomerase enzyme activity in benign and malignant gynaecologic pathologies.

Authors:  Ilhami Gül; Ozgür Dündar; Serkan Bodur; Yusuf Tunca; Levent Tütüncü
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

5.  Rates of Anovulation in Adolescents and Young Adults with Moderate to Severe Primary Dysmenorrhea and Those without Primary Dysmenorrhea.

Authors:  Laura C Seidman; Kathleen M Brennan; Andrea J Rapkin; Laura A Payne
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-10-07       Impact factor: 1.814

6.  Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use.

Authors:  Emily G Jacobs; Candyce Kroenke; Jue Lin; Elissa S Epel; Heather A Kenna; Elizabeth H Blackburn; Natalie L Rasgon
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

7.  The expression levels of stem cell markers importin13, c-kit, CD146, and telomerase are decreased in endometrial polyps.

Authors:  Jianguo Hu; Rui Yuan
Journal:  Med Sci Monit       Date:  2011-08

8.  Experimental evaluation of central pain processes in young women with primary dysmenorrhea.

Authors:  Laura A Payne; Laura C Seidman; Myung-Shin Sim; Andrea J Rapkin; Bruce D Naliboff; Lonnie K Zeltzer
Journal:  Pain       Date:  2019-06       Impact factor: 7.926

Review 9.  Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic.

Authors:  Leo Bockeria; Vladimir Bogin; Olga Bockeria; Tatyana Le; Bagrat Alekyan; Erik J Woods; Amalia A Brown; Thomas E Ichim; Amit N Patel
Journal:  J Transl Med       Date:  2013-03-05       Impact factor: 5.531

10.  Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells.

Authors:  Chunxiao Zhou; Tara A Steplowski; Hallum K Dickens; Kimberly M Malloy; Paola A Gehrig; John F Boggess; Victoria L Bae-Jump
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.